SCHEMBL3174098

SCHEMBL3174098

c1cnc2c(c1)=NCN=2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13811987 0.70
SCHEMBL2935846 0.69 TDP2 (0.32)
SCHEMBL10670205 0.68 ALDH1A1 (0.33)
SCHEMBL28481228 0.68 ALDH1A1 (0.33)
SCHEMBL10980109 0.67
SCHEMBL12890999 0.66 NPC1 (0.48)
SCHEMBL10909605 0.65 NOS3 (0.34)
SCHEMBL3378330 0.63
Boric Acid SCHEMBL22581646 0.62 MGLL (0.33)
SCHEMBL4646997 0.60 HTT (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024136524-A1 ORGANIC ELECTROLUMINESCENT DEVICE 솔루스첨단소재 주식회사 2024-06-27 WO disclosed
WO-2024136526-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 솔루스첨단소재 주식회사 2024-06-27 WO disclosed
WO-2023211162-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 솔루스첨단소재 주식회사 2023-11-02 WO disclosed
US-11800731-B2 Organic electroluminescent device SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-10-24 US disclosed
US-11800731-B2 Organic electroluminescent device SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-10-24 US disclosed
US-11706976-B2 Organic electroluminescent device containing exciton confinement layer SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-07-18 US disclosed
US-11706976-B2 Organic electroluminescent device containing exciton confinement layer SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-07-18 US disclosed
US-20230192757-A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS SAGE THERAPEUTICS, INC. 2023-06-22 US disclosed
US-20220006021-A1 ORGANIC ELECTROLUMINESCENT DEVICE SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2022-01-06 US disclosed
US-20210367178-A1 ORGANIC ELECTROLUMINESCENT DEVICE SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2021-11-25 US disclosed
US-7268158-B2 6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH) ASTRAZENECA AB (SE) 2007-09-11 US disclosed
US-7122545-B2 Imidazo-benzothiazoles HOFFMANN-LA ROCHE INC. (US) 2006-10-17 US disclosed
EP-1636217-A1 2-IMIDAZO-BENZOTHIAZOLES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2006-03-22 EP disclosed
US-20050227290-A1 Novel coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-10-13 US disclosed
US-6867222-B2 Nociceptin analogs EURO-CELTIQUE, S.A. (LU) 2005-03-15 US disclosed
WO-2004101558-A1 2-IMIDAZO-BENZOTHIAZOLES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 WO disclosed
US-20040229862-A1 Imidazo-benzothiazoles F. HOFFMAN-LA ROCHE AG (CH) 2004-11-18 US disclosed
US-6806289-B1 SUCH AS AMMINE (2-AMINO-3-PICOLINE) DICHLOROPLATINUM(II); EFFICIENCY AND SELECTIVITY FOR DESTROYING TRANSFORMED CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-10-19 US disclosed
US-5547978-A ENDOPEPTIDASE INHIBITORS MEIJI SEIKA KAISHA, LTD. (JP) 1996-08-20 US disclosed
US-5547978-A ENDOPEPTIDASE INHIBITORS MEIJI SEIKA KAISHA, LTD. (JP) 1996-08-20 US disclosed